Literature DB >> 29213657

Role of cognitive reserve in progression from mild cognitive impairment to dementia.

Ricardo F Allegri1, Fernando E Taragano1, Hugo Krupitzki1, Cecilia M Serrano1, Carol Dillon1, Diego Sarasola1, Mónica Feldman1, Graciela Tufró1, María Martelli1, Viviana Sanchez1.   

Abstract

Cognitive reserve is the ability to optimize performance through differential recruitment of brain networks, which may reflect the use of alternative cognitive strategies.
OBJECTIVES: To identify factors related to cognitive reserve associated with progression from mild cognitive impairment (MCI) to degenerative dementia.
METHODS: A cohort of 239 subjects with MCI (age: 72.2±8.1 years, 58% women, education: 12 years) was assessed and followed for five years (2001 to 2006).
RESULTS: In the first year, 13.7% of MCI converted to dementia and 34.7% converted within three years (78.3% converted to Alzheimer's dementia). Risk factors for those who converted were education less than 12 years, MMSE score less than 27, Boston naming test score less than 51, IQ (Intelligence Quotient) less than 111, age over 75 years, lack of occupation at retirement, and presence of intrusions in memory recall (all account for 56% of the variability of conversion).
CONCLUSIONS: MCI patients are a population at high risk for dementia. The study of risk factors (e.g. IQ, education and occupation), particularly those related to cognitive reserve, can contribute important evidence to guide the decision-making process in routine clinical activity and public health policy.

Entities:  

Keywords:  cognitive reserve; dementia; mild cognitive impairment; risk factors

Year:  2010        PMID: 29213657      PMCID: PMC5619527          DOI: 10.1590/S1980-57642010DN40100005

Source DB:  PubMed          Journal:  Dement Neuropsychol        ISSN: 1980-5764


Cognitive reserve is the ability to optimize performance through differential recruitment of brain networks, which may reflect the use of alternative cognitive strategies. The idea of reserve against brain damage stems from the repeated observation that there does not appear to be a direct relationship between the degree of brain pathology and the clinical manifestation of the damage.[1] Several studies have suggested that differential susceptibility to dementia level is related to variables such as education, literacy, IQ and engagement in leisure activities.[2-7] The concept of cognitive reserve posits that individual differences in how tasks are processed might provide differential reserve against brain pathology.[8] Although cognitive decline without dementia has commonly been considered a normal consequence of brain aging, cognitive impairment can mark the onset of dementia. A number of clinical definitions have been proposed to describe these cognitive deficits. Mild cognitive impairment (MCI) was defined by Petersen et al.[9] as a transitional state that can precede dementia; however, conversion rates remain controversial. The development of cognitive reserve is associated with genetic predisposition and exposure to and interaction with favorable environments (education, engagement in cognitively stimulating activities and occupation).[7] However, limited data are available regarding the role of cognitive reserve in conversion from MCI to dementia.[2-5] This investigation analyzed the conversion from MCI to dementia in our “CEMIC cohort”, and explored the risk factors related to cognitive reserve associated with transition in patients at risk of dementia.

Methods

Design and setting

This was a prospective cohort study of outpatients with MCI (CEMIC Cohort). The study was performed with the approval of the institutional review board. Each participant or his/her legal representative provided informed consent for participation.

Subjects

Between January 2001 and January 2006, 1491 consecutive outpatients were screened at our Dementia Clinic (Servicio de Investigación Neuropsicológica, SIREN) at the CEMIC Institute. Of these subjects, 239 met inclusion criteria for mild cognitive impairment[10] and were followed at least twice every 4 months. Patients were referred by general practitioners (45%), neurologists (27%), psychiatrists (16%) and others (12%). Subjects were typically referred because they had experienced cognitive impairment at work or in activities of daily living, or because they were worried about their cognitive functioning.

Procedures

Data collected at baseline included socio-demographic and clinical variables including age, education level expressed in years, gender, marital status, retirement status, occupational status, socio-economic level and number of consultations. Each subject underwent a uniform structured evaluation, including medical history, complete neurological examination; neuropsychological assessment (see below) and the Beck Depression Inventory.[11] Physical examination and laboratory tests were performed as clinically appropriate for each patient. Neuro-imaging examinations using brain CT scan, MRI or SPECT, as appropriate, were assessed.

Neuropsychological assessment

At baseline, patients were assessed with an extensive neuropsychological battery that included the Mini Mental State Examination, MMSE[12] (a validated[14] Argentine adaptation[13]), Signoret Memory Battery,[15] Boston Naming Test[16] (local Spanish adaptation[17]), Verbal Fluency,[18] Trail making test[19] and Wechsler Abbreviated Scale of Intelligence- WASI.[20]

Clinical diagnosis

Dementia diagnoses were made according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition[21] while AD diagnoses were based on the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and related Disorders of Association criteria, respectively.[22] A diagnosis of MCI was reached if the patient met the following criteria:[10] The individual was neither normal nor demented; There was evidence of cognitive impairment, shown by either objectively measured decline over time or subjective report of decline by self or informant in conjunction with objective cognitive deficits; Activities of daily living were preserved and complex instrumental functions were either intact or minimally impaired. In this study, we considered evidence of cognitive deficit as when one of the objective neuropsychological tests showed at least 1.5 SD below the mean value for age- and education-matched healthy subjects. Patients were excluded from the cohort if they had cerebrovascular disorders (defined by a score of 5 or higher on the Hachinski Ischemic Score)[23] or a history of neurological or major psychiatric disease or unstable general medical conditions. Raters examined each patient and both of the senior examiners (FT, RFA) reviewed data from each visit to determine the diagnosis of MCI at each time point and to ascertain whether a given patient had converted to dementia.

Follow up and outcome assessment

Patients were assessed at baseline and every 4 months or when necessary, using a comprehensive approach. Longitudinal analyses were based on completers with more than 2 evaluations. The median follow up for MCI patients was 24 months.

Statistical analysis

Categorical variables were expressed as percentages and for continuous variables, mean and standard deviations were estimated, while for non-normally distributed variables, medians and percentiles were considered. To compare frequency differences by diagnosis of conversion or non-conversion to dementia, univariate analyses were performed using the Chi-square test. Student t-tests were used to compare continuous variables between groups, while the nonparametric Wilcoxon rank sum test was applied to compare non-normally distributed variables between groups. Survival analyses were then performed to assess the association between time to onset of dementia and the analyzed variables. The main outcome was a diagnosis of dementia. Time to this event was considered an outcome of interest. The follow-up period was from the initial observation to conversion to dementia or to the study end point. Cox proportional hazards models were also estimated to test the multivariate associations between multiple explanatory variables and conversion to dementia in patients with MCI. Effects are shown as hazard ratios (HR), with 95% confidence intervals (95%CI). For all analyses, the STATA 8.0 statistical software package was used.

Results

239 participants were followed up for 5 years (median 24.15 months; 10th percentile: 9 and 90th percentile: 51.8). Demographic data are shown in Table 1. Loss during follow-up (including death) was less than 12%.
Table 1

Demographic data.

Patients (number)239 
Age at entry (mean±SD)72.3±7.8 
Sex (male, number and %)9841%
Marital Status (Married, number and %)15967%
Education (median in years) 12 
Work (retired, number and %)18276%
Follow-up  
    Median (months)24.15 
    10th Percentile9.00 
    90th Percentile51.89 
Number of visits  
    Median7 
    10th Percentile2 
    90th Percentile21 
MMSE score (median)28 
CDR score (median)0.5 
Demographic data.

Conversion to dementia in patients with MCI

Figure 1 shows age-adjusted Kaplan-Meier plots for conversion to dementia in patients with MCI. The annual rate of conversion was 13.7%.
Figure 1

Age-adjusted Kaplan-Meier survival curve for patients with MCI.

Age-adjusted Kaplan-Meier survival curve for patients with MCI. Table 2 provides data on rates of conversion to dementia and also shows the type of degenerative dementia to which MCI patients converted at month 36.
Table 2

Conversion from MCI to dementia.

Patients converted (n, %)83 (34.7)
Cumulative time at risk  (months)6902.16
Incidence rate per month (%)1.2
Percent converted at month 60 (95%CI)54.4% (45.5-62.5)
Type of conversion at month 36 
    No conversion, n (%)156 (65.3)
    Alzheimer's disease, n (%)65 (27.2)
    Frontotemporal dementia, n (%)15 (6.3)
    Lewy Body Dementia, n (%)3 (1.3)
Conversion from MCI to dementia. As shown in Table 3, converters to dementia were more likely to be older, without occupation at retirement, lower educated and with lower MMSE scores than non converters. At baseline, MCI converters to dementia showed poorer episodic memory (delayed recall and recognition) and semantic memory (naming-BNT, semantic fluency and vocabulary) than MCI non-converters. The presence of intrusions and perseverations was significantly higher in converters. Both populations had similar affective symptoms.
Table 3

Summary of characteristics for converters and non-converters.

 Non converters (n=177)Converters (n=75)Hazard Ratio(95% Conf. Int.)p value
Sociodemographics      
    Age, years (mean,SD)70.8 (+7.9)75.0 (7.0)1.061.031.10<0.001
    Sex, male (n, %)78 (44%)25 (33%)0.670.411.090.11
    Married (n, %)121 (68%)48 (64%)0.820.371.820.63
    Not working (n, %)127 (72%)66 (88%)4.481.0918.30.03
    Education, median12110.480.300.760.002
Neuropsychological assessment      
     Mini Mental State (mean, SD)27.4 (0.18)26.1 (0.5)-4.940.690.85<0.001
Memory Battery (Signoret)      
     Paragraph recall, median5.54.5-2.010.810.990.04
     Paragraph delayed recall, median4.53.5-2.510.810.970.01
     Verbal Serial learning, median77-1.370.811.030.17
     Verbal Serial free recall, median54-2.160.820.990.03
     Cued recall, median77-0.040.911.090.96
     Recognition, median1110-3.620.730.911<0.001
     Intrusions, median012.671.091.85<0.001
Language      
     Boston naming test, median5348-4.460.900.96<0.001
     Semantic fluency, median1613-3.260.870.96<0.001
     Phonologic fluency, median1213.50.770.961.070.44
Attention and Executive Functions      
     Digit Span, median86-3.680.740.91<0.001
     Trail making A, median55591.300.991.010.19
     Trail making B, median55591.320.991.000.18
     Perseverations, mean, SD50 (28.2)45 (60.0)3.061.121.68<0.001
WASI      
     Vocabulary, median4451.54.611.011.03<0.001
     Similarities, median39382.481.001.020.01
     Block design, median34340.890.991.010.37
     Matrix reasoning, median37391.540.991.020.12
     Verbal IQ, mean (SD)11099-4.670.940.97<0.001
     Performance IQ, mean (SD)9791-3.650.940.98<0.001
     Global IQ, mean (SD)10393.5-5.050.930.96<0.001
Affective symptoms      
    Beck Depression Inventory, median99.50.920.981.050.36
Summary of characteristics for converters and non-converters. The relative risks for the probability of progression to dementia are listed in Table 4. The multivariate analysis showed that the risk for developing dementia in people diagnosed with MCI increases by 63% in those aged over 75, by 64% with education level less than 12 years, increases two-fold when lacking an occupation, 96% with global IQ less than 111, 93% with a naming score less than 51 on the Boston naming test, and 194% with a score less than 27 on the MMSE. Each additional point on the Global IQ provided a 3.6% increase in protection against the development of Dementia.
Table 4

Relative risk predictors for conversion to dementia in multivariate analysis.

PredictorHazard ratiozp value95% CI
Age over 75 1.6342.030.0431.016-2.628
Education less than 12 years1.6401.990.0421.075-2.760
Not working 2.4092.300.0221.137-5.104
Global IQ less than 1110.964-2.570.0100.938-0.991
Vocabulary score 3.9434.420.0002.146-7.237
Naming score less than 511.9322.150.0321.059-3.526
Mini Mental State less than 272.9473.350.0011.566-5.548
MCI amnesic type 2.6962.440.0151.215-5.977
Relative risk predictors for conversion to dementia in multivariate analysis. We performed a factorial analysis (Table 5) in which education (less than 12 years), MMSE (less than 27) and naming (less than 51 on BNT) were used as factor 1 and these accounted for 26.2% of the variability of conversion to dementia, factor 2 was age and lack of occupation at retirement, explaining an additional 15%, factor 3 was vocabulary and presence of intrusions in episodic memory (free recall) explaining an additional 14.3%. Taken together, all these factors accounted for 56% of the variability of conversion from MCI to dementia.
Table 5

Factorial analysis.

(main component factors; 3 factors retained)
FactorEigenvalueDifferenceProportionCumulative
12.365720.933270.26290.2629
21.432450.142340.15920.4220
31.290110.142520.14330.5654
Rotated factor Variable Loading
 123
Age-0.091130.76348-0.10332
Education less than 12-0.66230-0.19017-0.08836
Not Working0.201920.782930.07879
MMSE less than 270.76879-0.267350.07529
Naming less than 510.694900.17108-0.37709
Vocabulary less than 490.15144-0.25318-0.72847
Intrusions in Memory0.03003-0.174610.80564
Global IQ less than 1110.788210.14386-0.07444
Factorial analysis.

Discussion

There is a clinical cognitive continuum which runs from normal aging to degenerative dementia. Cognitive decline without dementia has commonly been considered a normal consequence of brain aging, but can also indicate the onset of dementia. The boundary between normal aging and very early dementia is becoming a major focus of research. The idea of aging-effects versus disease is not new; in 1962, Kral et al.[24] described “benign senescent forgetfulness” (BSF) in which fairly unimportant details of an experience (e.g. a name, a place or a date) are not recalled but do not interfere with activities of daily living and do not progress to dementia. Kral also recognized that “differentiation of the benign and malignant types of senescent forgetfulness does not necessarily mean that there are two neuropathological processes”. These diagnostic criteria were not precise, nor were they validated in controlled longitudinal studies. These cognitive changes in aging have been assigned various terms, such as age-associated memory impairment,[25] late-life forgetfulness[26] and aging-associated cognitive decline.[27] These terms have been used largely to explain the limits of normal aging, to characterize individuals who are neither normal nor demented. Such terms were criticized for being inaccurate.[28] Mild cognitive impairment was first described in the late 1990s by Flicker et al.[29] and later by Petersen et al.[9] Petersen proposed a clinical continuum ranging from normal aging through to mild cognitive impairment and on to dementia. MCI was not normal aging: this construct was intended to be a clinical description of persons who were destined to develop dementia.[9] Currently, an understanding of prodromal states or early clinical presentations of Alzheimer’s disease (AD), is a significant priority since it would aid in early detection, facilitate early treatment, and lead to prevention.[28] In clinical-based studies the typical rate at which MCI patients’ progress to dementia is 10 to 15% per year. In contrast, the incidence rates for the development of dementia in normal elderly subjects is 1 to 2% per year.[9] In our clinical referral study involving 239 patients from South America, the annual rate of conversion from MCI to dementia was 13.7%. Among the MCI patients who converted to dementia, 78.3% were AD, 18% FTD, and 3.6% LBD. AD is the natural evolution of MCI which has converted to degenerative dementia. Several predictive features of conversion from MCI to dementia are beginning to emerge when baseline factors are studied separately. High risk was found for increasing age, lack of occupation in the elderly, low formal education level, and difficulty coping with common situations. At the pre-dementia stage, converted patients showed lower general cognitive function, and greater episodic memory impairment (lower delayed recall with no improvement in recognition and presence of intrusion), semantic memory impairment (naming, verbal fluency and vocabulary), and dysexecutive syndrome (perseveration) than non-converted patients. This amnesic syndrome of the hippocampal type found in prodromal AD (lower delayed recall with no improvement in recognition and presence of intrusion) resemble our findings and was described as pre-dementia stage of Alzheimer’s disease by several groups.[30-33] In the factorial analysis, education (less than 12 years), MMSE (less than 27) and naming (less than 51) accounted for 26.2% of the variability of conversion to AD, while aging and “leisure inactivity” explained an additional 15%, and vocabulary (less than 49) and the presence of intrusions in memory test explained a further 14.3%. Most of these risk factors were related to the concept of cognitive reserve.[1-7] Cognitive reserve is the ability to optimize performance through differential recruitment of brain networks, which may reflect the use of alternative cognitive strategies.[1] Cognitive reserve is the hypothesized capacity of the mature adult brain to resist the effects of disease or injury which are capable of causing clinical dementia in an individual possessing less cognitive reserve[34]. Stern proposed that active and passive components were involved.[1] Active components encompass high level of education and complex occupations[1] whereas passive components comprise brain structures involved in memory retrieval, problem solving, and intelligence quotient[34]. Low education level in this population increased the risk of progression to dementia in line with results reported by Kryscio et al.[35] Epidemiological studies have established low educational attainment as a significant risk factor for dementia.[36-38] In our study, education level and occupational complexity can be divided into late age as the active factor, and global IQ and old age as the passive factor. All these cognitive reserve-related factors accounted for 56% of the variability of conversion from MCI to dementia. The main conclusions of this study are: In the MCI “CEMIC Cohort” (239 MCI subjects with 5 years of follow-up), 34.7% converted to Degenerative Dementia within 3 years. Most of the MCI patients converted to Alzheimer Disease (78.3%) The most significant Risk Factors for Conversion from MCI to Dementia were related to cognitive reserve (passive: IQ and age; active: Education and Occupation). Finally, our results suggest that devising a (cognitive reserve related) risk factor protocol may be helpful in protecting MCI individuals at high risk of conversion. This study can contribute important evidence to guide the decision-making process in routine clinical activity and Public Health policy on aging.
  25 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

2.  Influence of leisure activity on the incidence of Alzheimer's disease.

Authors:  N Scarmeas; G Levy; M X Tang; J Manly; Y Stern
Journal:  Neurology       Date:  2001-12-26       Impact factor: 9.910

Review 3.  What is cognitive reserve? Theory and research application of the reserve concept.

Authors:  Yaakov Stern
Journal:  J Int Neuropsychol Soc       Date:  2002-03       Impact factor: 2.892

4.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

5.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

6.  Senescent forgetfulness: benign and malignant.

Authors:  V A KRAL
Journal:  Can Med Assoc J       Date:  1962-02-10       Impact factor: 8.262

7.  Classification criteria for mild cognitive impairment: a population-based validation study.

Authors:  K Ritchie; S Artero; J Touchon
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

8.  Premorbid reading activity and patterns of cognitive decline in Alzheimer disease.

Authors:  R S Wilson; D A Bennett; D W Gilley; L A Beckett; L L Barnes; D A Evans
Journal:  Arch Neurol       Date:  2000-12

9.  Literacy and memory decline among ethnically diverse elders.

Authors:  Jennifer J Manly; Pegah Touradji; Ming-Xin Tang; Yaakov Stern
Journal:  J Clin Exp Neuropsychol       Date:  2003-08       Impact factor: 2.475

10.  Amnestic MCI or prodromal Alzheimer's disease?

Authors:  Bruno Dubois; Martin L Albert
Journal:  Lancet Neurol       Date:  2004-04       Impact factor: 44.182

View more
  10 in total

1.  A clinical dose of angiotensin-converting enzyme (ACE) inhibitor and heterozygous ACE deletion exacerbate Alzheimer's disease pathology in mice.

Authors:  Shuyu Liu; Fujiko Ando; Yu Fujita; Junjun Liu; Tomoji Maeda; Xuefeng Shen; Kota Kikuchi; Aoi Matsumoto; Mirai Yokomori; Chiaki Tanabe-Fujimura; Hiroshi Shimokata; Makoto Michikawa; Hiroto Komano; Kun Zou
Journal:  J Biol Chem       Date:  2019-05-09       Impact factor: 5.157

2.  Transitions across cognitive states and death among older adults in relation to education: A multistate survival model using data from six longitudinal studies.

Authors:  Annie Robitaille; Ardo van den Hout; Robson J M Machado; David A Bennett; Iva Čukić; Ian J Deary; Scott M Hofer; Emiel O Hoogendijk; Martijn Huisman; Boo Johansson; Andriy V Koval; Maaike van der Noordt; Andrea M Piccinin; Judith J M Rijnhart; Archana Singh-Manoux; Johan Skoog; Ingmar Skoog; John Starr; Lisa Vermunt; Sean Clouston; Graciela Muniz Terrera
Journal:  Alzheimers Dement       Date:  2018-02-01       Impact factor: 21.566

3.  Relationship between Brain Age-Related Reduction in Gray Matter and Educational Attainment.

Authors:  Patricia Rzezak; Paula Squarzoni; Fabio L Duran; Tania de Toledo Ferraz Alves; Jaqueline Tamashiro-Duran; Cassio M Bottino; Salma Ribeiz; Paulo A Lotufo; Paulo R Menezes; Marcia Scazufca; Geraldo F Busatto
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

4.  Detection of mild cognitive impairment in a community-dwelling population using quantitative, multiparametric MRI-based classification.

Authors:  Mark J R J Bouts; Jeroen van der Grond; Meike W Vernooij; Marisa Koini; Tijn M Schouten; Frank de Vos; Rogier A Feis; Lotte G M Cremers; Anita Lechner; Reinhold Schmidt; Mark de Rooij; Wiro J Niessen; M Arfan Ikram; Serge A R B Rombouts
Journal:  Hum Brain Mapp       Date:  2019-02-25       Impact factor: 5.038

5.  Resting-state prefrontal EEG biomarkers in correlation with MMSE scores in elderly individuals.

Authors:  Jungmi Choi; Boncho Ku; Young Gooun You; Miok Jo; Minji Kwon; Youyoung Choi; Segyeong Jung; Soyoung Ryu; Eunjeong Park; Hoyeon Go; Gahye Kim; Wonseok Cha; Jaeuk U Kim
Journal:  Sci Rep       Date:  2019-07-18       Impact factor: 4.379

Review 6.  Cognitive Reserve, Alzheimer's Neuropathology, and Risk of Dementia: A Systematic Review and Meta-Analysis.

Authors:  Monica E Nelson; Dylan J Jester; Andrew J Petkus; Ross Andel
Journal:  Neuropsychol Rev       Date:  2021-01-08       Impact factor: 7.444

7.  Effects of Cognitive Reserve in Alzheimer's Disease and Cognitively Unimpaired Individuals.

Authors:  Dong Hyuk Lee; Sang Won Seo; Jee Hoon Roh; Minyoung Oh; Jungsu S Oh; Seung Jun Oh; Jae Seung Kim; Yong Jeong
Journal:  Front Aging Neurosci       Date:  2022-02-07       Impact factor: 5.750

8.  Neuropsychological profile in the preclinical stages of dementia: principal component analysis approach.

Authors:  Claudia Rivera-Fernández; Nilton Custodio; Marcio Soto-Añari
Journal:  Dement Neuropsychol       Date:  2021 Apr-Jun

9.  The genetic risk of Alzheimer's disease beyond APOE ε4: systematic review of Alzheimer's genetic risk scores.

Authors:  Hannah Stocker; Tobias Möllers; Laura Perna; Hermann Brenner
Journal:  Transl Psychiatry       Date:  2018-08-24       Impact factor: 6.222

10.  Cognitive Reserve, Leisure Activity, and Neuropsychological Profile in the Early Stage of Cognitive Decline.

Authors:  Sook Young Lee; Jae Myeong Kang; Da Jeong Kim; Soo Kyun Woo; Jun-Young Lee; Seong-Jin Cho
Journal:  Front Aging Neurosci       Date:  2020-10-26       Impact factor: 5.750

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.